Navigation Links
Identification of gene

The mystery of what causes the fatal autoimmune disease Systemic Lupus Erythematosis has been solved by the identification of a possible genetic link.

Researchers at the University of California, San Diego School of Medicine (UCSD) uncovered the possible genetic link to SLE. Their report in a nationa journal say that a gene has been identified in mice which, if absent, causes symptoms remarkably similar to human SLE.//

SLE is an incurable and potentially fatal multi-organ disease that turns victims’ immune systems against them. The disease affects about one in 300 people, 90 per cent of them being women.It causes damage to kidneys, liver, brain, heart, spleen, joints, and lungs.

The investigators from UCSD,found that mice with a genetic mutation in an enzyme called alpha-mannosidase II develop lupus-type symptoms. This enzyme helps to form cell-surface carbohydrate structures called N-glycans, which enable the immune system to distinguish self from non-self.

In people with lupus and other autoimmune diseases such as arthritis, the body’s white blood cells, instead of destroying invading bacteria and viruses, attack normal organs. While these cells appear normal in lupus sufferers, the victims’ tissues and organs still appear ravaged by an attacking immune system.

Researchers had previously noticed that changes in N-glycans could lead to autoimmune disease. After pinpointing a gene which produces an enzyme that starts the glycan formation pathway, researchers bred mice without this gene. They found the gene-deficient mice had much lower levels of N-glycans, and abnormally shaped N-glycans molecules. At the same time, these mice had high levels of antibodies, kidney inflammation and other tissue damage.

Senior author of the study, Professor Jamey Marth said: "this is an entirely new manner by which autoimmune disease can occur, by a gene controlling carbohydrate formation. These findings provide new ins
'"/>




Page: 1 2

Related medicine news :

1. New Gene Identification Help Asthma Treatments
2. The Use of Radio Frequency Identification ( RFID) to tackle the growing menace of counterfeit drugs
3. Protein Markers for Identification of Brain Tumor
4. Identification Of Gene Sequence To Promote Growth Of New Arteries
5. Colour Identification Lies Wholly On the Left Hemisphere of the Brain.
6. Novel Technique For Identification And Treatment Of Neurodegenerative Diseases
7. Combined Imaging Approach may Provide Better Identification of Difficult-to-diagnose Brain Clots
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Identification gene

(Date:12/4/2009)...olesterol-lowering drugs known as statins are amon...new study by researchers at Fred Hutchinson Cancer...t stem cell transplant patients from one of the mo... therapy: graft-versus-host disease, or GVHD. The ...of the journal Blood . , In a retrospective stud...
(Date:12/4/2009)...ledge of risks, many hesitate to take breast cance...HealthDay News) -- Worries about side effects are ...n at high risk for breast cancer are willing to ta...w study finds. , In an effort to inform women a...ers at the University of Michigan Comprehensive Ca...
(Date:12/4/2009)... TrekDesk Inventor Showcasing Innovative... (Vocus) December 4, 2009 -- A valley invent...proven to help individuals lose weight, prevent di...uctivity will be showcasing the product at Saturda...ter Gallery., , , , , TrekDesk has been featured...
(Date:12/4/2009)..., JACKSONVILLE, Fla., Dec. 4 Tod...rds for their work in improving the health of Flor...tion for a Healthy Florida,s 2009 Sapphire Award c...y statewide award that recognizes and promotes org...dressing health disparities within their communiti...
(Date:12/4/2009)...SHINGTON, Dec. 4 As Con...lan, Family Research Council (FRC) today announced...es in Louisiana to survey each household on provis...e abortion funding, rationing, higher taxes, and g...Survey participants who express opposition to the ...
Breaking Medicine News(10 mins):Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3Health News:FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover 2
...d on findings of a recent study researchers say an...have little effect on // hospitalizations, respira...The finding was especially true for children who r...ected. However, for children under age 2 who recei...
...rding to a recent study researchers say, Monteluka...s mediate inflammation // in the body and play a r... asthma in young children by about 32 percent whil... of the children received low-dose montelukast onc...
...icosteroids, which are routinely used to treat pat...to death, //reports a study conducted at London Sc...esearchers had studied the effect of this drug on ...s. The results showed that there seems to be an in...
...rding to a recent study researchers say those in t...e associated with // an increased risk of suicidal...ents with depression and other clinical conditions...atients taking SSRIs and those taking other drugs,...
...ford Hospital in US is one of the first to impleme...ings of the heart without having to operate.// The... of the patient’s heart. The technology uses an “i... preferences to cardiac surgeons even before they ...
...nt studies have shown that oral examination may no...urbances in patients.// Earlier patients suffe...have mostly been related to snoring in their sleep..., heart problems, stroke, and obesity, breathing p...
Other Medicine News:
(Date:12/4/2009)..., SAN DIEGO, Calif., Dec. 4 Sune...ice company, today announced the appointment of Ph...Officer. In this role, Mr. Ranker will lead all S...ns including finance, accounting, IT, IR, administ... the Company,s senior management team. ,, "One...
(Date:12/4/2009)..., BETHESDA, Md., Dec. 4 Drs. Neal... prostate-specific antigen (PSA) recurrence from t...biochemical recurrence rate in a Phase III pivotal...jection) or monthly leuprolide in prostate cancer ...tate cancer patients who received FIRMAGON 240/80 ...
(Date:12/3/2009)..., ACTON, Mass., Dec. 3 /PRNewswire-FirstCall/ -...Holdings, Inc. (NYSE: HRC ), today announced the... Equipment Manufacturer) business website www.Al...e Allen Amatech(TM) brand identity and includes an...etailed descriptions and design specifications for...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Fifteenth US Patent Issued for aTyr Pharma Novel Biotherapeutic 56522 1Fifteenth US Patent Issued for aTyr Pharma Novel Biotherapeutic 56522 2Arctic Sun Again Preferred Choice of Top Ranked U S Hospitals for Therapeutic Temperature Management 56520 1Arctic Sun Again Preferred Choice of Top Ranked U S Hospitals for Therapeutic Temperature Management 56520 2Arctic Sun Again Preferred Choice of Top Ranked U S Hospitals for Therapeutic Temperature Management 56520 32009 India Excellence in Healthcare Awards 56519 12009 India Excellence in Healthcare Awards 56519 22009 India Excellence in Healthcare Awards 56519 32009 India Excellence in Healthcare Awards 56519 4
...if., Jan. 9 Rigel,Pharmaceuticals, Inc. (Nasdaq: ...g patients in a Phase 1 study to evaluate the safe...potent inhibitor of Janus Kinase,3 (JAK3), as a po...hritis,(RA), psoriasis and other immune disorders....ctive in reducing arthritic symptoms, bone destruc...
...mafore Pharmaceuticals Inc.,today announced that a...,Issue 1: 206-215) reports that SF1126, the compan... antiangiogenic activity., The paper, entitled "A...nhibitor Prodrug, SF1126, with Antitumor and Antia...es conducted by Semafore and collaborators at,Chil...
Other Medicine Technology:Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders 2Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders 3Semafore's SF1126 Exhibits Antitumor and Antiangiogenic Activity 2
Sundt Slim-Line Temporary Aneurysm Clip
Micro Needle Holders With Lock
Vascular Clamps B-3
Rhoton #12 Straight Point Needle
Medicine Products: